Nu-Med Plus (NUMD) Interest Coverage Ratio Growth (3y) (2015 - 2023)
Nu-Med Plus (NUMD) Interest Coverage Ratio Growth (3y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -7.80% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -1.00% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 12.94% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 9.28% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -35.05% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -4.98% |
| 10 | Nu-Med Plus | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 42.27% |
| Sep 30, 2023 | 52.28% |
| Jun 30, 2023 | 56.57% |
| Mar 31, 2023 | 16.17% |
| Dec 31, 2020 | 33.58% |
| Sep 30, 2020 | -83.69% |
| Jun 30, 2020 | -126.64% |
| Mar 31, 2020 | -59.77% |
| Dec 31, 2019 | -26.74% |
| Sep 30, 2019 | -31.38% |
| Jun 30, 2019 | 19.74% |
| Mar 31, 2019 | 99.61% |
| Dec 31, 2018 | 32.99% |
| Sep 30, 2018 | 13.03% |
| Jun 30, 2018 | -29.19% |
| Mar 31, 2018 | -1.68% |
| Dec 31, 2017 | -99.12% |
| Sep 30, 2017 | -23.81% |
| Jun 30, 2017 | -22.33% |
| Mar 31, 2017 | 51.21% |